Leptomeningeal Metastasis
Showing 1 - 25 of 1,827
Leptomeningeal Metastasis Trial in Aarhus (CSI)
Not yet recruiting
- Leptomeningeal Metastasis
- CSI
-
Aarhus, DenmarkAarhus University Hospital
Feb 28, 2023
NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- (no location specified)
Mar 27, 2023
NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)
Recruiting
- Non-small Cell Lung Cancer
- Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
-
Chongqing, Chinachongqing University Three Gorges Hospital
Apr 11, 2023
Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)
Recruiting
- Leptomeningeal Metastasis
- +2 more
- Camrelizumab or envafolimab
-
Hebei, ChinaThe Second Hospital of Hebei Medical University
May 19, 2022
Leptomeningeal Metastases Trial in Changchun (Pemetrexed (1), Pemetrexed (2), Folic Acid)
Recruiting
- Leptomeningeal Metastases
- Pemetrexed (1)
- +4 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Sep 29, 2022
Non-small Cell Lung Cancer With Central Nervous System
Recruiting
- Lung Cancer With Central Nervous System Metastasis
- lung cancer with brain /leptomeningeal metastasis
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 4, 2023
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)
Recruiting
- Leptomeningeal Metastasis
- Pemetrexed
- Radiotherapy
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 8, 2022
Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and
Recruiting
- Leptomeningeal Metastasis
- +2 more
- intrathecal nivolumab and intrathecal ipilimumab
-
Geneva, Switzerland
- +2 more
Dec 18, 2022
Leptomeningeal Metastasis, Solid Tumor, Adult Trial in United Kingdom, United States (radiolabeled DPTA-omburtamab)
Withdrawn
- Leptomeningeal Metastasis
- Solid Tumor, Adult
- radiolabeled DPTA-omburtamab
-
Los Angeles, California
- +7 more
Jul 12, 2022
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Radiation Therapy
- +2 more
-
Tampa, Florida
- +1 more
Dec 30, 2022
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)
Not yet recruiting
- NSCLC Associated With Leptomeningeal Metastases
- Tislelizumab, pemetrexed
- (no location specified)
Nov 21, 2023
NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)
Recruiting
- NSCLC
- +3 more
- TY-9591 Tablets
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022
Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))
Recruiting
- Leptomeningeal Metastases
- Deferoxamine (DFO)
-
Basking Ridge, New Jersey
- +6 more
Jun 27, 2022
Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)
Enrolling by invitation
- Non Small Cell Lung Cancer
- Furmonertinib Mesilate Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Apr 3, 2023
Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial
Withdrawn
- Breast Cancer
- Leptomeningeal Metastasis
- Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
- +2 more
-
Lille, Hauts-de- France, France
- +1 more
Oct 5, 2021
Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago
Not yet recruiting
- Breast Carcinoma
- +2 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Nov 14, 2023
NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line
Recruiting
- NSCLC
- +2 more
- almonertinib
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 25, 2021
Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation
Active, not recruiting
- Leptomeningeal Metastases
- Involved-field Photon Radiation Therapy
- +3 more
-
Basking Ridge, New Jersey
- +7 more
Jul 22, 2022
Metastatic Breast Cancer, Leptomeningeal Disease Trial in Baltimore, Saint Louis, Winston-Salem (High-dose Methotrexate (8
Recruiting
- Metastatic Breast Cancer
- Leptomeningeal Disease
- High-dose Methotrexate (8 gm/m2; HD-MTX)
-
Baltimore, Maryland
- +2 more
May 5, 2022
Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)
Recruiting
- Brain Metastases
- Leptomeningeal Metastasis
- GDC-0084
- whole brain radiation therapy radiation
-
Miami, Florida
- +9 more
Jan 3, 2023
NSCLC, Leptomeningeal Metastasis, EGFR Activating Mutation Trial in Nanchang (Almonertinib, Bevacizumab)
Not yet recruiting
- NSCLC
- +2 more
-
Nanchang, Jiangxi, ChinaThe Second Afiliated Hospital of Nanchang University
Jun 26, 2021